Related by context. All words. (Click for frequent words.) 75 Nanobody ® 75 Nanobodies 74 Nanobodies R 73 Nanobody 71 therapeutic monoclonal antibodies 69 siRNA therapeutic 69 protein kinase inhibitor 68 siRNA therapeutics 68 HuCAL antibody 68 humanized monoclonal antibodies 68 recombinant antibodies 68 therapeutic monoclonal antibody 67 OMP #M# 67 cMET 67 rxRNA 67 ESBA# 67 IMA# 67 immune modulating 67 mAbs 67 CCX# 67 Anticalins R 67 XmAb 67 kidney urologic 67 NovaBay Aganocide compounds 66 NNR Therapeutics 66 antisense drugs 66 VersaFilm 66 biomarker identification 66 radezolid 66 peptide antigens 66 anticancer therapeutics 66 antisense oligonucleotides 66 PDE# inhibitors 66 antiviral compounds 66 CYT# potent vascular disrupting 66 NEUGENE 66 biologic therapeutics 66 HIV integrase inhibitors 66 p# inhibitor 66 antisense compounds 66 TLR8 66 Anticalins 66 sd rxRNA 65 adrenergic regulation 65 PORxin TM platforms 65 preclinically 65 Prodarsan ® 65 CCR9 antagonist 65 TNF alpha antagonist 65 GRN# 65 Curaxin 65 RNAi therapeutic targeting 65 HCV protease inhibitors 65 PROCHYMAL 65 MEK inhibitor 65 AEG# 65 Sym# 65 investigational therapies 65 Adnectin 65 LNP formulations 65 Stapled Peptide 65 A3 adenosine receptor 65 renin inhibitors 65 MEK inhibitors 65 LHRH antagonists 65 cleavable linker 65 HDAC inhibition 65 Nanobodies TM 65 Virulizin ® 65 immunotoxin 64 nucleoside analogues 64 CBLC# 64 Prodarsan R 64 anti tubercular 64 NTDDS 64 molecularly targeted therapies 64 vinca alkaloid 64 small molecule activators 64 monoclonal antibody therapeutics 64 microRNA biomarkers 64 Aviptadil 64 dAbs 64 indibulin 64 molecular biomarkers 64 preclinical efficacy 64 affinity antibodies 64 EndoTAG TM -1 64 JAK inhibitors 64 immunological diseases 64 molecularly targeted 64 rxRNA compounds 64 DsiRNA 64 cellular immunotherapy 64 DepoVax TM 64 radionuclide therapy 64 ophthalmology oncology 64 P#X# 64 LEAPS TM 64 Medarex UltiMAb R 64 OncoVEX 64 rxRNA TM compounds 64 ONCONASE R 64 anticoagulant reversing agent 64 Tarvacin TM 64 mda 7 64 monoclonal antibodies mAbs 64 lentiviral vectors 64 histone deacetylase HDAC 64 AMPK activators 64 TLR agonists 64 JAK2 inhibitor 64 GRNVAC1 64 ImmunoVEX HSV2 64 ADME properties 64 JAK3 64 NXL# 64 ENMD # 63 ATL# [001] 63 synthetic retinoid 63 GFT# 63 cancer immunotherapies 63 immatics 63 novel peptide 63 anticancer therapies 63 humanized antibodies 63 Smac mimetic 63 ChronVac C R 63 SNT MC# 63 glycosylation profile 63 immune modulatory 63 aptamer therapeutics 63 CORT # 63 JAK kinases 63 biased ligand 63 encapsulates siRNAs 63 THR beta agonist 63 novel antiviral therapeutics 63 validating biomarkers 63 intracellular signaling pathways 63 biodegradable nanoparticles 63 nanobodies 63 Viprovex TM 63 Azedra 63 monoclonals 63 RONDEL ™ 63 vivo validation 63 HuCAL antibodies 63 liposomal formulations 63 flavopiridol 63 oral prodrug 63 direct thrombin inhibitors 63 PhG alpha 1 63 favorable pharmacokinetic profile 63 CB1 antagonists 63 CR# vcMMAE 63 antiangiogenic agents 63 novel antibody therapeutics 63 Spiegelmer 63 MMP inhibitors 63 EHT AGN 63 Cytomegalovirus CMV 63 CB2 receptor 63 R#/MEM # 63 YONDELIS 63 novel peptides 63 humanized antibody 63 antitumour 63 carbohydrate polymers 63 anti CD3 63 DXL# 63 vivo potency 63 EndoTAG TM 63 telomerase inhibitor 63 CD# antibody [001] 63 polyclonal 63 HTS assay 63 Nanobody R 63 metaglidasen 63 cytostatic 63 Anticalins ® 63 ddRNAi 63 AKT inhibitor 63 gastro intestinal inflammation 62 GeoVax vaccine 62 Smac mimetics 62 Pseudomonas aeruginosa infections 62 Affibody ® molecules 62 proprietary PEGylation 62 virus AAV 62 systemic RNAi 62 PI3K inhibitor 62 anticancer agents 62 oncolytic 62 cannabinor 62 Symadex 62 ALN PCS 62 Litx 62 CRLX# 62 TG# [003] 62 Altastaph 62 Phylomer ® 62 BCR ABL inhibitors 62 PORxin TM 62 CEQ# 62 ALN TTR 62 oral PTH 62 vascular disrupting agents 62 rifamycins 62 antisense inhibitors 62 GLPG# 62 mAb 62 SERCA2a 62 Aurora kinase 62 molecular abnormalities 62 effector function 62 LEX System 62 EGFR HER 62 FTIs 62 nanocarriers 62 OnDose TM 62 antisense drug 62 synthetic peptides 62 MET amplification 62 CytoFabTM 62 systemically administered 62 novel therapeutic antibodies 62 PEGylated interferon 62 tumor hypoxia 62 PARP inhibitors 62 HQK 62 isoform selective 62 eTag assays 62 mTOR inhibitors 62 metabonomics 62 insertional mutagenesis 62 proteasome inhibitors 62 neuropsychiatric diseases 62 CRACM 62 chemical entities NCEs 62 NP2 Enkephalin 62 PSMA ADC 62 multitargeted 62 MVA BN R 62 antibody reagents 62 nifurtimox 62 engineered RAP peptides 62 PGL# 62 OHR/AVR# 62 FLT3 62 Panzem 62 protein kinase inhibitors 62 siRNA sequences 62 AAV vector 62 anti angiogenic drugs 62 Isis antisense 62 prostone 62 vidofludimus 62 Golimumab 62 investigational monoclonal antibody 62 Cytolin R 62 PEG SN# 62 cilengitide 62 Pertuzumab 62 polymerase inhibitors 62 immuno modulatory 62 busulfan 62 Squalamine 62 systemic RNAi therapeutic 62 Spiegelmer ® 62 immunotherapeutic approaches 62 PEGylated 62 DermaVir Patch 62 Factor VIIa 62 polyketide 62 SiMoA 62 mTOR inhibition 62 short interfering RNA 62 S#P# 62 ALK inhibitors 62 fusion enhancers 62 INxin TM 62 nanoviricides 62 nanomedicines 62 recombinant albumin 62 mGluR2 NAM 62 tubulin inhibitor 62 oxidative stress inducer 62 ADAMTS# 62 NITD# 62 pDNA vaccines 62 Protein Kinase C 62 cytotoxins 62 lipid nanoparticles 62 inhibiting mTOR 62 Onconase 62 XmAb# 62 therapeutic antibodies 62 CXCR4 receptor 62 hematological indications 62 GI motility disorders 62 PLX MS 62 ACV1 62 RGB # 62 Seliciclib 62 siRNA compounds 61 Alexza Staccato 61 enzyme inhibitor 61 sd rxRNA compounds 61 ALN TTR# 61 endothelin antagonist 61 epigenetic therapeutics 61 theranostics 61 immunotherapeutic vaccine 61 Monoclonal antibody 61 oral antiviral 61 DiLA2 61 plasma kallikrein 61 ATL/TV# 61 AMPAKINE 61 Hedgehog inhibitor 61 Lisofylline LSF 61 oncolytic viruses 61 BHT DNA 61 HuLuc# 61 hESC derived cardiomyocytes 61 biocatalytic 61 lipid particles 61 DermaVir 61 AFFITOME R 61 NNRTIs 61 HCV protease inhibitor 61 immunoregulation 61 Aplidin 61 HCD# [002] 61 NEUGENE R 61 TLR9 agonists 61 MGd 61 anti angiogenic agents 61 Pancreate 61 novel immunotherapies 61 mGluR5 antagonist 61 lentiviral vector 61 commercialize deforolimus 61 including eniluracil ADH 61 radiolabeled TM# 61 outer membrane proteins 61 hedgehog pathway 61 immunomodulatory properties 61 splice variants 61 TBC# 61 Tß4 61 TÎ ² 4 61 Anticalin 61 cardiometabolic disorders 61 HCV replication 61 riociguat 61 Archexin 61 XmAb ® 61 candidate CRLX# 61 BNC# 61 Chemetics R 61 dSLIM 61 miR #a [002] 61 endostatin 61 Epstein Barr Virus EBV 61 Cyclosert TM 61 PDE4 inhibitor 61 therapeutic mAbs 61 immunotoxins 61 JVRS 61 RNAi therapeutic 61 metabolomic profiling 61 LentiVector technology 61 HepDirect R 61 TGR5 61 Novavax VLP vaccine 61 OxBC 61 HCV NS5B polymerase 61 otelixizumab 61 antagomirs 61 UltiMAb 61 forodesine 61 DepoVax 61 Tarvacin Anti Viral 61 IAP inhibitor 61 SGLT Inhibitors 61 HGS# 61 antigen sparing 61 anticancer compounds 61 Olaparib 61 endosomal release 61 ARIKACE ™ 61 Therapeutic antibodies 61 BioSilicon 61 virosome 61 tumor antigen 61 pathophysiological effects 61 optical biosensors 61 resolvins 61 YONDELIS R 61 immunogens 61 Xanafide 61 amikacin 61 MCSP respectively 61 chemically modified siRNA 61 tranilast 61 either acutely decompensated 61 BiTE 61 pharmacologic intervention 61 antibody mediated 61 Solazed 61 microtubule inhibitor 61 IgG1 antibody 61 deacetylase inhibitors 61 cytoprotective 61 inhibit metastasis 61 hormone gastrin 61 BRAF kinase 61 anti secretory 61 microRNA biology 61 immunomodulation 61 ANAVEX #-# [001] 61 transgenic rats 61 VDAs 61 bioactive molecules 61 monoclonal antibodies 61 Biopump 61 p# inhibitors 61 GPR# agonist 61 Curaxins 61 liposomal delivery 61 IMC #B 61 proprietary BiTE ® 61 GAP #B# 61 M. pneumoniae 61 Ebola SNALP 61 adenoviral vectors 61 druggable targets 61 AAV vectors 61 BRAF inhibitor 61 proteasome inhibitor 61 #ME# 61 somatic mutations 61 INS# [001] 61 heterologous 61 PET tracers 61 Protexia ® 61 Zalypsis 61 vivo preclinical 61 integrin receptors 61 CD# CEA 61 optimal dosing regimens 61 Monoclonal antibodies 61 ASPIRE HIGHER 61 CD# monoclonal antibody 61 AV HALT 61 siRNAs targeting 61 romazarit 61 TriRima 61 cytotoxics 61 constipation OIC 61 Thiovir 61 multiplex assay 61 ulimorelin 61 VEGF inhibitors 61 targeting CD# 61 GPCR targets 61 Hemopurifier 61 insulin analogs 61 LNPs 61 novel VDA molecule 61 OncoVEX GM CSF 61 Vandetanib 61 microdose 61 nanocarrier 61 cyclophilin inhibitors 60 non nucleoside HCV 60 CGEN # 60 cardiotoxic effects 60 PEGPH# 60 Tyrima 60 Civacir 60 TPI ASM8 60 TTR gene 60 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 60 monoclonal antibodies MAbs 60 TKM PLK1 60 Gleevec resistant 60 oncolytic virus 60 siRNA nanoparticles 60 HSP# inhibitors 60 ALN VSP 60 intestinal mucosal 60 vivo pharmacology 60 VEGF receptor 60 recombinant polyclonal antibodies 60 CCR1 60 GMX# 60 resolvin 60 CDDO Im 60 deforolimus 60 throughput RNAi 60 catalytic antibodies 60 alvespimycin 60 rBChE 60 immunology oncology 60 leopard frog ONCONASE 60 Wnt signaling pathway 60 Resten NG 60 therapeutic antibody 60 #beta HSD1 60 anti Parkinsonian 60 PDE4 inhibitors 60 stem cell transplantations 60 small molecule thrombopoietin 60 IAP inhibitors 60 FVIIa 60 daptomycin 60 anti amnesic 60 stem cell pluripotency 60 PI3K/mTOR 60 boron chemistry 60 Aurora kinase inhibitor 60 nebulized budesonide 60 budesonide foam 60 MEK ERK 60 Sapacitabine 60 pharmacological chaperone 60 therapeutic radiopharmaceuticals 60 genomic profiling 60 Enkephalin 60 protein tyrosine phosphatase 1B 60 huC# DM4 60 NS#/#A protease 60 dacetuzumab 60 TRO# 60 buccal delivery 60 myelofibrosis polycythemia vera 60 PRT# 60 Dr. Marlies Sproll 60 synovial cells 60 dermatologic diseases 60 POTELLIGENT ® 60 oligonucleotide therapeutics 60 MTP inhibitors 60 allogeneic HSCT 60 Src inhibitors 60 RhuDex ® 60 predictive biomarkers 60 adenoviral 60 immunotherapeutics 60 Hepatocellular Carcinoma HCC 60 SPC# [001] 60 INCB# [001] 60 immunosuppressive regimens 60 BrachySil TM 60 Amplimexon 60 protein tyrosine phosphatase 60 antibody fragment 60 NCEs 60 IgG1 antibodies 60 BRAF inhibitors 60 NS5b 60 receptor tyrosine kinase inhibitor 60 systemic siRNA 60 antitumoral 60 trastuzumab Herceptin 60 ATL# [002] 60 JAK#/JAK# 60 MAb 60 Omacetaxine 60 siRNA knockdown 60 nalbuphine ER 60 chimeric monoclonal antibody 60 Aurora kinase inhibitors 60 prophylactic vaccines 60 clinical pharmacology studies 60 immunomodulatory 60 oral JAK1 60 targeting PCSK9 60 vitamin D analogs 60 antiangiogenesis 60 BAL# [001] 60 FSH receptor 60 polyclonal antibodies 60 anionic backbone 60 MT#/MEDI-# 60 immunomodulatory therapy 60 angiogenesis inhibition 60 lumiliximab 60 ImmunoGen TAP technology 60 nucleotide analog 60 Exelixis compounds 60 trastuzumab Herceptin ® 60 RNA antagonist 60 Vorinostat 60 Lisofylline 60 DNA methyltransferases 60 thetreatment 60 Locked Nucleic Acid LNA 60 peptide therapeutics 60 isavuconazole 60 Fibroblast Growth Factor Receptor 60 XmAb ™ 60 renin inhibition 60 oral talactoferrin 60 S/GSK# 60 potent cytotoxic 60 cyclophilin inhibitor 60 targeted radiotherapeutic 60 polyketides 60 SAR# [002] 60 UsiRNAs 60 rxRNA ™ compounds 60 Cyclosert 60 Trofex 60 Vacc 4x 60 CCR5 mAb 60 Radilex 60 HepaMate ™ 60 ganaxolone 60 enzymatic pathways 60 intranasal delivery 60 Mycograb 60 Lenocta 60 HuCNS SC ® 60 oral JAK#/JAK# inhibitor 60 neuroprotective properties 60 DNA demethylation 60 Cardiotoxicity 60 aerosolized KL4 surfactant 60 BACcel 60 Lixivaptan 60 MTP inhibitor 60 antitumor 60 Tumor Response 60 relapsed MM 60 bioinformatic approaches 60 PLX cells 60 nitric oxide donating 60 Listeria vaccine 60 TransVax ™ 60 macrolide antibiotics 60 mertansine 60 CytoFab ™ 60 Exherin TM 60 delipidation 60 pharmacokinetic interactions 60 prodrugs 60 silico prediction 60 Guanilib 60 OXi# 60 GGF2 60 antibody MAb 60 FAAH 60 C5aR 60 antitumor effects 60 molecular determinants 60 Tekmira SNALP technology 60 CobaCyte 60 intradermal injection 60 recombinant adeno associated 60 EGFR inhibitors 60 HCV polymerase 60 therapeutically relevant 60 Dyax phage display 60 EyeGate 60 antibiotic resistant bacterial infections 60 adeno associated viruses 60 aerosolized AAT 60 immuno therapeutic 60 microRNA therapeutics 60 JAK inhibitor 60 delafloxacin 60 PI3K inhibitors 60 Rigel R# 60 ERYtech 60 factor receptor FGFR 59 imetelstat 59 Umbilical cord stem cells 59 CMV vaccine 59 obatoclax 59 Mipomersen 59 neovascular diseases 59 ceftazidime 59 Spiegelmers 59 punctal plug drug 59 metabolite identification 59 FGFR 59 preclinical compounds 59 carbapenem 59 gastrointestinal stromal tumors GISTs 59 anti CD3 antibody 59 histone deacetylase inhibitors 59 TriGrid ™ 59 HIF PH inhibitors 59 subcutaneous immunoglobulin 59 adenovirus vector 59 EGFR tyrosine kinase inhibitors 59 DP b# 59 HuMax EGFr 59 chemotherapeutics 59 genetics immunology 59 TKM ApoB 59 midstage trials 59 monoclonal antibody mAb 59 CIMZIA ™ 59 Sudhir Agrawal D.Phil 59 VA# [002] 59 miRview mets 59 RONDEL TM 59 Ceflatonin 59 lipid nanoparticle 59 Micromet BiTE 59 siRNA molecules 59 IMiDs R 59 adipose derived stem cell 59 MorphoSys proprietary 59 short hairpin RNAs 59 Alequel 59 HGS ETR1 mapatumumab 59 Cx# [002] 59 Interferon alpha 59 MAbs 59 echinocandin 59 endogenous ligands 59 oral FTY# 59 Vaxfectin TM 59 Sphingomab 59 phage display libraries 59 epothilones 59 Ramoplanin 59 siRNA mediated 59 echinocandins 59 HIV protease 59 molecular imaging radiopharmaceuticals 59 lymphoid tumors 59 Cogane 59 antiangiogenic 59 antibody therapeutics 59 #T# L1 59 diagnostic biomarker 59 ganetespib 59 zileuton 59 immune stimulatory 59 pharmacodynamic markers 59 talabostat 59 Gamunex C 59 DuraSite 59 liposome formulations 59 NEUMUNE 59 TLR antagonists 59 antibody fragments 59 velafermin 59 masitinib 59 DNA gyrase 59 oral dnaJP1 59 KRAS oncogene 59 Daclizumab 59 recombinant polyclonal antibody 59 imexon 59 GVAX ® 59 AERx ® 59 transfection reagents 59 nucleotide analogs 59 chlamydial 59 iRGD 59 nonviral 59 nutlin 3a 59 HCV NS3 protease 59 peptide synthesis 59 rhITF 59 gp# protein [002] 59 Aganocide TM 59 Optiquel ™ 59 dendritic cell vaccines 59 TNFa 59 SERMs 59 Spiegelmers R 59 AtuRNAi 59 PRLX # 59 staphylococcal vaccine 59 TACI Ig 59 neutralizing antibody 59 Spiegelmers ® 59 plasmid DNA vaccine 59 MVA BN ® 59 Proellex TM 59 kinase profiling 59 Cerashield 59 MYDICAR ® 59 TLR9 agonist 59 antimitotic 59 M.tb 59 Scil Proteins 59 chemokine receptor 59 TH# cells 59 histone deacetylase inhibitor 59 iPSC 59 intraoperative radiotherapy 59 Alocrest 59 metabolomic profiles 59 GlycArt 59 liposomal 59 immunological responses 59 telomerase activator 59 Streptomyces bacteria 59 omega interferon 59 ThGRF 59 glycomics 59 Human cl 59 TRIM5a 59 galiximab 59 Lpathomab 59 selective inhibition 59 Immunotherapeutic 59 selective orally bioavailable 59 OvaRex R 59 M2 subunit 59 GelSite R polymer 59 aneuploid cells 59 immunologic diseases 59 lipidoid 59 anti CD# antibodies 59 MediGene focuses 59 Cloretazine 59 Enzastaurin 59 fibrotic disease 59 4CMenB 59 VIBEX MTX 59 prophylactic vaccine 59 monoclonal antibody MAb 59 MVA BN 59 XP# XP# 59 haplotype map 59 DiLA2 Platform 59 orally administered inhibitor 59 CDK inhibitors 59 protein homeostasis 59 cystinosis patients 59 #D#C# 59 IMPDH 59 TRAIL induced apoptosis 59 epigenetic therapies 59 Novosom 59 deCODE chemistry 59 histone deacetylase HDAC inhibitors 59 macrocycles 59 DepoVax ™ 59 elotuzumab 59 Hedgehog antagonist 59 Deforolimus 59 DNA plasmids 59 Biomerk Tumorgrafts 59 P#X# antagonist 59 HepDirect technology 59 ALDH br cells 59 IMiDs ® 59 cGMP manufacture 59 anthracycline chemotherapy 59 PROSTVAC TM 59 polymer conjugate technology 59 small molecule inhibitors 59 Gene Ontology terms 59 dengue viruses 59 CCR5 inhibitors 59 novel anticancer 59 LY# [003] 59 clevidipine 59 blood coagulation disorders 59 Vidofludimus 59 viral antigens 59 SMT C# 59 proteins peptides 59 triterpenoids 59 genomics proteomics 59 Angiocept 59 novel immunotherapeutic 59 Aethlon Hemopurifier ® 59 class mGluR5 inhibitor 59 cationic lipid 59 beta interferons 59 NSCLC tumors 59 p# activation 59 MYCAMINE 59 pan HDAC inhibitor 59 radiolabeled monoclonal antibody 59 gamma secretase inhibitor 59 Fleximer R 59 REP# 59 ZFP Therapeutics 59 humanised antibody 59 orally dosed 59 CFTR inhibitors 59 Fc receptor 59 Pimavanserin 59 BRAF mutation 59 NOD mouse 59 transgenic mouse models 59 HER2 overexpression 59 meganucleases 59 metabolomic 59 RNA antagonists 59 Ataluren 59 Angioblast 59 enzastaurin 59 experimental autoimmune encephalomyelitis 59 alpha antagonist 59 anti EGFR antibody 59 GLP toxicology studies 59 methylation markers 59 AGS PSCA 59 PARP inhibition 59 HepDirect prodrug 59 treating neuropathic pain 59 pharmacologic agents 59 humanized monoclonal 59 elvucitabine 59 tiapamil 59 enzymatically active 59 cytomegalovirus infections 59 AFFiRiS 59 Gag polymorphisms 59 glucagon receptor 59 recombinant erythropoietin 59 AVE# 59 intravenous immunoglobulin IVIg 59 biomarker assays 59 nosocomial pneumonia 59 HbF 59 telomerase activators 59 refractory metastatic 59 BioVant 59 torezolid phosphate 59 tumor antigens 59 epithelial tumors 59 orally bioavailable 59 polioviruses 59 rhIL 7 59 synDNA TM 59 effector functions 59 mtDNA mutations 59 Kinase inhibitors 59 Monoclonal Antibody 59 theranostic 59 antisense therapeutics 59 faropenem 59 Dacogen decitabine 59 AtuPLEX 59 SIgN 59 vascular disrupting 59 CTSAs 59 BIIR 59 ncRNA 59 recombinant enzyme 59 anticancer therapy 59 nicotinic alpha 7 59 COMT inhibitors 59 Shigamabs ® 59 NF kB signaling 59 virology immunology 59 Aganocide ® 59 liposomal formulation 59 TCAD therapy 59 Trophos 59 immunomodulator 59 Nucleic acids 59 immunized mice 59 DACH platinum 59 Elotuzumab 59 ACAT2 59 Pharmos pipeline 59 acetonide FA 59 potently inhibit 58 ZFP TF 58 humanised monoclonal antibody 58 developing TB4 58 sodium thiosulfate STS 58 SIRT1 activators 58 outlicensing 58 non nucleoside 58 predictive toxicology 58 STAT3 signaling 58 MitoQ 58 adenosine receptor 58 Epothilones 58 herpesviruses 58 ISF# 58 AeroLEF TM 58 phenotyping 58 Glypromate 58 Combivir Kivexa 58 secretory diarrhea 58 transgenic mouse model 58 Diamyd ® 58 c MET 58 vascular disrupting agent 58 Solulin 58 glucokinase activator